Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
X4 Pharmaceuticals, Inc.

Start price
Target price
Perf. (%)
€1.04
30.04.24
€4.67
30.04.25
-23.19%
29.07.24

HC Wainwright 
30.04.24 50%
buy
Harmonic

Start price
Target price
Perf. (%)
€10.20
30.04.24
€16.82
30.04.25
34.12%
14:03

Needham & Company LLC 
30.04.24 50%
buy
Enova Intl Inc.

Start price
Target price
Perf. (%)
€57.50
30.04.24
-
30.04.25
37.39%
31.07.24

Saftman 
30.04.24 50%
buy
Weight Watchers International

Start price
Target price
Perf. (%)
€34.15
29.04.24
€290.69
29.04.25
-
01.10.19

Citigroup Inc. 
29.04.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
-0.75%
03.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.12
29.04.24
€1.70
31.07.26
-1.79%
06.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%
buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€7.90
29.04.24
€10.00
31.01.26
-41.18%
16:53

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%
buy
Perficient Inc.

Start price
Target price
Perf. (%)
€40.60
29.04.24
€71.89
29.04.25
72.41%
09:30

Barrington Research 
29.04.24 50%
buy
Kadant Inc.

Start price
Target price
Perf. (%)
€262.00
29.04.24
€336.13
29.04.25
25.30%
31.07.24

Barrington Research 
29.04.24 50%
buy
Asure Software

Start price
Target price
Perf. (%)
€6.90
29.04.24
€15.87
29.04.25
36.23%
31.07.24

Barrington Research 
29.04.24 50%
buy
Kinsale Capital Group Inc

Start price
Target price
Perf. (%)
€340.30
29.04.24
€410.83
29.04.25
22.11%
17:10

Truist Financial Co. 
29.04.24 50%
buy
Thermon Group Holdings

Start price
Target price
Perf. (%)
€30.20
29.04.24
€39.21
29.04.25
-0.66%
31.07.24

CJS Securities 
29.04.24 50%
buy
First Interstate BancSystem Inc

Start price
Target price
Perf. (%)
€25.00
29.04.24
€34.57
29.04.25
17.75%
31.07.24

Piper Sandler 
29.04.24 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€3.71
29.04.24
€9.34
29.04.25
20.59%
16:40

TD Cowen 
29.04.24 50%
buy
Atlantic Tele-Network Inc.

Start price
Target price
Perf. (%)
€18.40
29.04.24
€28.02
29.04.25
43.61%
31.07.24

BWS Financial 
29.04.24 50%
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.38
29.04.24
€20.55
29.04.25
-
20.03.24

Mizuho 
29.04.24 50%
buy
Flotek Industries

Start price
Target price
Perf. (%)
€0.67
29.04.24
€6.54
29.04.25
-
09.10.23

Alliance Global Partners 
29.04.24 50%
buy
XOMA Corp.

Start price
Target price
Perf. (%)
€24.80
29.04.24
€37.36
29.04.25
8.06%
31.07.24

SVB Leerink LLC 
29.04.24 50%
buy
MGP Ingredients Inc.

Start price
Target price
Perf. (%)
€74.00
29.04.24
€112.08
29.04.25
0.15%
31.07.24

Wedbush 
29.04.24 50%
buy
Universal Technical Institute

Start price
Target price
Perf. (%)
€14.20
29.04.24
€16.81
29.04.25
23.24%
29.07.24

Rosenblatt Securities 
29.04.24 50%
buy
National Bank Holdings A

Start price
Target price
Perf. (%)
€30.40
29.04.24
€37.83
29.04.25
27.16%
31.07.24

Hovde Group 
29.04.24 50%
buy
Richardson Electronics

Start price
Target price
Perf. (%)
€10.05
29.04.24
€12.14
29.04.25
10.11%
31.07.24

Northland Securities 
29.04.24 50%
sell
Enochian Biosciences Inc

Start price
Target price
Perf. (%)
€1.39
29.04.24
-
29.04.25
-51.15%
31.07.24

Growths slower than the competition
Probably not worthwhile Investment
Higher risks for its business
Lokrim 
29.04.24 20%
buy
Biodexa Pharmaceuticals Plc

Start price
Target price
Perf. (%)
€1.09
29.04.24
-
29.04.25
-16.97%
11.05.24

Capable Management
Could be worthwhile Investment >10% per year
Little innovation
me8 
29.04.24 0%
buy
Super Micro Computer

Start price
Target price
Perf. (%)
€812.90
29.04.24
€1,000.00
29.04.25
-8.22%
11.05.24

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Capable Management
Low dividend yield expected
skatcup 
29.04.24 80%